T1	Limitation 23542 23544	We
T4	Limitation 24488 24496	However,
T5	Limitation 24668 24671	The
T6	Limitation 28553 28556	The
T7	Limitation 28812 28820	However,
T8	Limitation 29104 29112	Patients
T9	Limitation 29367 29375	Patients
T10	Limitation 29532 29540	Finally,
T3	SampleSize 24519 24568	identifying such patients prospectively difficult
T14	UnderpoweredStudy 29367 29489	Patients excluded owing to inability to provide informed consent had higher severity of illness scores than those included
T15	CompositeIntervention 29104 29206	Patients with polymicrobial infections and receiving additional antibiotics were included in the study
T16	Intervention 28889 28943	more patients allocated to vancomycin were bacteraemic
T17	Population 24585 24666	the trial included only patients with microbiologically confirmed MRSA infections
T11	SampleSize 24668 24757	The main reason precluding inclusion of patients was inability to obtain informed consent
T2	SampleSize 28589 28639	the small sample size of patients with bacteraemia
T12	NonstandardTreatmentCharacteristics 29541 29666	the dosing of vancomycin and trough levels achieved (≥15 µg/mL in only 67% of patients) were lower than currently recommended
T13	Control 23542 23574	We defined no exclusion criteria
